How a new long-acting HIV drug combo tackles resistance
|
A new long-acting HIV treatment could expand
options for people who have trouble taking daily pills and whose virus is
resistant to some commonly ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.